حدد سهمًا أو عملة مشفرة في شريط البحث للحصول على ملخص
UMP Healthcare Holdings Ltd
0722UMP Healthcare Holdings Limited, an investment holding company, provides a range of medical and healthcare services in Hong Kong, Macau, and Mainland China. It operates in three segments, Hong Kong & Macau Corporate Healthcare Solution Services, Hong Kong & Macau Clinical Healthcare Services, and Mainland China Clinical Healthcare Services. The company offers general practice and family medicine; specialist consultation services, including internal medicine, surgery, pediatrics, cardiology, dermatology, otorhinolaryngology, orthopedics, ophthalmology, urology, gastroenterology and hepatology, radiology, endocrinology, and diabetes; and dental care services, such as dental implant, cosmetic dentistry, periodontal treatments, and orthodontics, as well as traditional Chinese medicines. It also provides physiotherapy services comprising muscle-strengthening, limb function, eye-hand coordination, and hand function trainings; day surgery and endoscopy; diagnostic imaging and laboratory; preventive medicines and health assessment; visa medical examination; vaccination and consultation; vision care and optometry; plastic, head, and neck surgeries; medical and cosmetics dermatology, and aesthetics; chronic disease management, such as hypertension, cardiovascular disease, diabetes, and joint diseases; and corporate healthcare solutions and third party administration services. In addition, the company offers WeWell Healthcare, a health service platform for family health management, recommending, and arranging professional medical and health services for each family member, including health checkup, vaccinations, and other specialist medical services referrals, etc. Further, it provides specialist consultation services. It serves insurance companies and corporations, and self-paid patients. The company was founded in 1990 and is headquartered in Central, Hong Kong. Address: Wing On House, Central, Hong Kong
Analytics
سعر الهدف في وول ستريت
18.76 HKDنسبة السعر إلى الأرباح
8.6العائد الربحي
7.67 %السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
الشخصيات الرئيسية 0722
تحليلات الأرباح 0722
نمو الأرباح على مدى 5 سنوات
62 %النمو المستمر
7 سنينمعدل الدفع 5 سنوات في المتوسط
86 %تاريخ الأرباح 0722
تقييم الأسهم 0722
المالية 0722
نتائج | 2019 | ديناميات |